University of Cincinnati: Genome Research Institute.

Ken Greis's Lab
Kenneth Greis, Associate Professor of Cancer and Cell Biology, is director of proteomics for the University and Children’s Hospital Medical Center. Dr. Greis focuses on technology development and the application of mass spectrometry to understand biochemical and biomedical systems. This direction was initiated in the early 1990s while studying glycosylation and phosphorylation in herpes viruses and has continued to this day in areas of protein characterization, proteomics and compound screening. Over the past 10 years, Dr. Greis has built and led protein characterization and proteomics mass spectrometry groups within two pharmaceutical companies. In those roles, he developed significant expertise in mass spectrometry and proteomics while collaborating in a variety of research areas including: signal transduction, angiogenesis, metabolic regulation, anti-infectives, musculoskeletal, inflammation and cancer. Dr. Greiss joined the University of Cincinnati, Genome Research Institute, as an associate professor in the Department of Molecular Oncogenesis in 2006. In this role, he is responsible for developing and applying advanced proteomics technologies both as core resources and as a collaborator with a variety of investigators. Dr. Greis also leads a centralized effort across the GRI, the University of Cincinnati College Medicine and the Cincinnati Children’s Hospital Medical Center in his role as Director of Proteomics. The research interests of the Greis group, beyond proteomics and protein characterization, include the development of a novel mass spectrometry-based compound screening approach as a label-free alternative to traditional high-throughput screening assays.

Selected Publications:
(none)